Form 4 Filing for Robert E. Landry

Robert E. Landry, a director at CYTOKINETICS INC (CYTK), reported a disposition of 1000 shares of Common Stock on September 15, 2026. The transaction was executed at a price of $72.13 per share. Following this transaction, Landry directly owns 8184 shares of the company's stock. The filing was made on Form 4, indicating a change in beneficial ownership.